Global shortage of two key treatments
Manx Care says there’s 'no immediate threat' to stroke patients, and those with heart conditions, due to a global shortage of two key treatments.
The Isle of Man, along with UK NHS trusts, is being asked to conserve supplies of two drugs - Alteplase and Tenecteplase - due to manufacturer issues.
The shortage is expected to last until early next year and hospitals are being asked to provide alternative treatments where appropriate.
Dr Sreeman Andole is the executive medical director, and stroke consultant, at Noble's Hospital:
Rider died after crashing into garden wall
Cannan: 'I will be proposing referendum on assisted dying'
Health Minister refused to be drawn into legalities of Roundhouse access issues
Man given suspended sentence for stealing £660 worth of Nike clothing
Police appeal for information after fire extinguisher incident
MHK brands public sector overpayments "breathtakingly incompetent"
